An effect of short-term treatment with fingolimod on redistribution of natural killer cell in patients with multiple sclerosis.
Phase of Trial: Phase IV
Latest Information Update: 26 Feb 2016
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 26 Feb 2016 New trial record